Binh Dinh Pharmaceutical and Medical Equipment JSC (DBD) — Cash Flow Reinvestment Rate
Binh Dinh Pharmaceutical and Medical Equipment JSC (DBD) has a Cash Flow Reinvestment Rate of 0.63x as of December 2025, reinvesting ₫135.54 Billion (capex ₫135.54 Billion ) from operating cash flow of ₫213.49 Billion. Check Binh Dinh Pharmaceutical and Medical Equ cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Binh Dinh Pharmaceutical and Medical Equipment JSC Cash Flow Reinvestment Rate (2020–2025)
Historical reinvestment intensity for Binh Dinh Pharmaceutical and Medical Equipment JSC across 6 annual periods. Explore DBD operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Binh Dinh Pharmaceutical and Medical Equipment JSC (2020–2025)
Year-by-year capital reinvestment analysis for Binh Dinh Pharmaceutical and Medical Equipment JSC. For live market cap and broader valuation context, see market cap of Binh Dinh Pharmaceutical and Medical Equ.
| Year | Reinvestment Rate | Total Reinvested (VND) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.13x | ₫693.35 Billion | ₫615.19 Billion | ₫408.57 Billion | ▲ +13.3% |
| 2024 | 0.99x | ₫263.38 Billion | ₫264.73 Billion | ₫148.75 Billion | ▲ +17.5% |
| 2023 | 0.85x | ₫248.93 Billion | ₫293.99 Billion | ₫133.69 Billion | ▼ -41.9% |
| 2022 | 1.46x | ₫240.52 Billion | ₫165.01 Billion | ₫82.83 Billion | ▲ +14.3% |
| 2021 | 1.27x | ₫149.86 Billion | ₫117.57 Billion | ₫54.64 Billion | ▲ +273.1% |
| 2020 | 0.34x | ₫72.73 Billion | ₫212.91 Billion | ₫59.73 Billion | — |